2026. Expression of Glioblastoma Molecular Markers and Sensitivity to Innate Immune Peptides LL-37 and Protegrin-1 as Predictors of Chemotherapy Response. London Journal of Medical and Health Research. 26, 2 (Feb. 2026), 15–25.